Ophthalmic Business News

Last year, we wrote about the five top financial mistakes Dr. Bhatia has seen in fellow physicians, especially at the beginning of their careers. We covered this for our Forward Thinking column in Orthopedics Today, a Healio publication.

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb, offers updates on the company’s pipeline.

LAS VEGAS — In this video from the ASCRS meeting, Chuck Hess, vice president and general manager of Bausch + Lomb’s U.S. surgical business, discusses ClearVisc dispersive ophthalmic viscosurgical device and other company updates.

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Tom Ruggia, president and CEO of Samsara Vision, discusses the company’s goal of returning vision to patients blinded by late-stage age-related macular degeneration.

LAS VEGAS — At the Eyecelerator@ASCRS meeting, Rajesh K. Rajpal, MD, discusses patient-reported outcomes from the Tecnis Eyhance and Tecnis Synergy IOLs (Johnson & Johnson Vision) and previews studies being presented at the ASCRS meeting.

LAS VEGAS — At the Eyecelerator@ASCRS meeting, Jeffrey Nau, PhD, MMS, president and CEO of Oyster Point Pharma, discusses OC-01 nasal spray for dry eye disease and two additional pipeline programs.

LAS VEGAS — At the Eyecelerator@ASCRS meeting, Ben Bergo, president and CEO of Visus Therapeutics, discusses Brimochol (carbachol and brimonidine tartrate), the company’s lead candidate for presbyopia.

LAS VEGAS — At the Eyecelerator@ASCRS meeting, Tom Mitro, president and chief operating officer at Aerie, discusses candidates that may help Aerie gain a foothold in other ophthalmic disease states, including a pan-VEGF inhibitor.

LAS VEGAS — At the Eyecelerator@ASCRS meeting, Richard Small, CPA, CEO of Neurotech Pharmaceuticals, offers a comprehensive update on the company’s current pipeline.

LAS VEGAS — At the Eyecelerator@ASCRS meeting, Euan Thomson, PhD, president of ophthalmology at Carl Zeiss Meditec, discusses the Zeiss Medical Ecosystem.